Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.
Pediatr Blood Cancer
; 57(2): 191-8, 2011 Aug.
Article
em En
| MEDLINE
| ID: mdl-21465637
ABSTRACT
This guideline provides clinicians caring for children with an approach to assessing the acute emetogenic potential of antineoplastic therapies. It was developed by an international, inter-professional panel of clinicians and researchers using AGREE and CAN-ADAPTE methods. The emetogenicity of antineoplastic agents was evaluated and ranked as high, moderate, low, or minimal. The emetogenicity of multiple-agent and multiple-day antineoplastic therapy was also classified. Gaps in the evidence used to underpin the guideline recommendations were identified. The contribution of this guideline to the prevention of antineoplastic-induced nausea and vomiting in individual children about to receive antineoplastic therapy requires prospective evaluation.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Vômito
/
Náusea
/
Neoplasias
/
Antineoplásicos
Tipo de estudo:
Etiology_studies
/
Guideline
Limite:
Adolescent
/
Child
/
Child, preschool
/
Humans
/
Infant
Idioma:
En
Ano de publicação:
2011
Tipo de documento:
Article